Blade Urban Air Mobility LLC Acquisition
Total Consideration
$92.4M
Purchase-Price Allocation
Goodwill
$75.1M
Assets Acquired
$112.8M
Liabilities Assumed
$21.7M
Contingent Earn-Out
$7.6M
Joby Aviation, Inc. — Key Metrics
3 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-1
Book Value Per Share
$2
Free Cash Flow Per Share
$-1
Cash Per Share
$0
Revenue Per Share
$0
OCF Per Share
$-1
Return on Equity
-80.1%
Return on Assets
-62.0%
Return on Invested Capital
-49.0%
Debt to Equity
0.00
Current Ratio
24.09
Quick Ratio
24.09
Asset Turnover
0.04
R&D / Revenue
1087.7%
SBC / Revenue
239.4%
Capex / Revenue
100.9%
Working Capital
$1.39B
Net Current Asset Value
$1.06B
Invested Capital
$1.41B
OCF / Net Income
0.55
FCF / Net Income
0.61
Accruals Ratio (Sloan)
-23.4%
Net Debt
$-1.41B
Net Debt / EBITDA
2.07
Interest Coverage
—
Cash Coverage
—
Capex Coverage
-9.46
Tangible Common Equity
$1.30B
TCE / Total Assets
72.5%
Goodwill / Total Assets
5.0%
NOPAT
$-568M
Cash ROIC
-48.6%
WC / Revenue
2593.8%
Capex / D&A
1.34
Reinvestment Rate
-1.4%
Asset Growth vs Revenue Growth
-39133.9%
Stock Price (FY-end)
$13
Market Cap
$10.91B
P/S Ratio
204.14
P/B Ratio
7.74
P/TB Ratio
8.38
Enterprise Value
$9.50B
EV / Sales
177.79
FCF Yield
-5.2%
Shareholder Yield
-1.2%
R&D Yield
5.3%
Capex Yield
0.5%
Shares Variation (YoY)
18.1%
Beta (5Y)
1.83
Cost of Equity
13.7%
52W High
$20
52W Low
$5
Trailing Return 1Y
47.8%
Trailing Return 5Y
12.8%
F-Score (Piotroski)
3.00
Z-Score (Altman)
14.44
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.
EPS — Consensus vs Actual
Revenue — Consensus vs Actual
Beat / Miss vs Estimate
Stock Price on Earnings Dates
Joby Aviation, Inc. — Effective Tax Rate ReconciliationNEW
Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.
Effective Rate Trend
| Reconciliation Line | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Federal Statutory Rate | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% |
| State & Local Income Taxes | 6.70% | 7.30% | 9.10% | 1.60% | 0.00% | 0.00% |
| Foreign Rate Differential | — | — | — | — | — | -0.40% |
| Other Adjustments | -0.20% | 0.10% | 6.30% | -16.80% | -3.50% | — |
| R&D Tax Credits | — | — | — | — | — | -3.40% |
| Valuation Allowance Change | -32.50% | -27.90% | -41.80% | -9.00% | -22.40% | -19.20% |
| Effective Tax Rate | 0.00% | 5.50% | 0.00% | 0.00% | 0.00% | -0.10% |
Cash vs Accrual
| Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Income Tax Expense (Accrual) | $31.0K | −$10.5M | $92.0K | $139.0K | $129.0K | $1.3M |
| Income Taxes Paid (Cash) | — | — | — | — | — | — |
Joby Aviation, Inc. — M&A AcquisitionsNEW
Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.
Aerospace Modular Autonomy Technology Company
Purchase-Price Allocation
Goodwill
$300.0K